| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052759844 |
| P356 | DOI | 10.1038/EJHG.2016.26 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ejhg.2016.26 |
| P932 | PMC publication ID | 4989210 |
| P698 | PubMed publication ID | 27049304 |
| P50 | author | Naveed Anjum Chikan | Q59683799 |
| Taseem A Mokhdomi | Q85800376 | ||
| P2093 | author name string | Asif Amin | |
| Asrar H Wafai | |||
| Shoiab Bukhari | |||
| Raies A Qadri | |||
| Nisar A Chowdri | |||
| Sajad H Wani | |||
| P2860 | cites work | MutationTaster2: mutation prediction for the deep-sequencing age. | Q52877992 |
| Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1 | Q81199599 | ||
| Pharmacogenetics, pharmacogenomics, and individualized medicine | Q23919667 | ||
| Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding | Q24291582 | ||
| Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 | Q24304277 | ||
| The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma | Q24312773 | ||
| The protein kinase family: conserved features and deduced phylogeny of the catalytic domains | Q27860528 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation | Q27860944 | ||
| Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
| Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules | Q28646549 | ||
| Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm | Q29547194 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| VEGF receptor signalling - in control of vascular function | Q29617256 | ||
| Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. | Q34136366 | ||
| Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy | Q34157098 | ||
| Signalling by receptor tyrosine kinases | Q34306539 | ||
| A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1 | Q34333820 | ||
| Predicting the functional effect of amino acid substitutions and indels | Q34441875 | ||
| Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? | Q35676065 | ||
| Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis | Q36369761 | ||
| Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood | Q36609494 | ||
| Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma | Q36747387 | ||
| Positive and negative modulation of angiogenesis by VEGFR1 ligands | Q37401612 | ||
| Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme | Q37446015 | ||
| Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. | Q38337364 | ||
| Affinity proteomics led identification of vimentin as a potential biomarker in colon cancers: insights from serological screening and computational modelling. | Q38947548 | ||
| A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration | Q40392328 | ||
| Role of VEGF-flt receptor system in normal and tumor angiogenesis. | Q40951691 | ||
| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. | Q43592482 | ||
| VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival. | Q50883768 | ||
| Measurement of phosphorylated extracellular signal-regulated kinase 1 and 2 in an undergraduate teaching laboratory with ALPHAscreen technology. | Q51764352 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1287-1293 | |
| P577 | publication date | 2016-04-06 | |
| P1433 | published in | European Journal of Human Genetics | Q2155433 |
| P1476 | title | A novel kinase mutation in VEGFR-1 predisposes its αC-helix/activation loop towards allosteric activation: Atomic insights from protein simulation | |
| P478 | volume | 24 |
| Q89425532 | Aqueous solution interactions with sex hormone-binding globulin and estradiol: a theoretical investigation | cites work | P2860 |
Search more.